| 2023-08-24 | Sale | Xenon Pharmaceuticals Inc. XENE | director | 25,000 0.0391% | $38.70 | $967,500 | +4.46% | |
| 2022-06-09 | Sale | PTC Therapeutics, Inc. PTCT | 738 0.001% | $27.20 | $20,074 | +65.46% | ||
| 2022-05-16 | Adverum Biotechnologies, Inc. ADVM | 30,000 0.0319% | $0.85 | $25,578 | +2.84% | |||
| 2022-01-07 | Sale | PTC Therapeutics, Inc. PTCT | director | 510 0.0007% | $38.52 | $19,648 | +5.33% | |
| 2021-06-09 | Sale | PTC Therapeutics, Inc. PTCT | director | 365 0.0005% | $41.88 | $15,288 | -5.67% | |
| 2021-03-31 | Adverum Biotechnologies, Inc. ADVM | director | 20,000 0.0207% | $10.02 | $200,338 | -77.38% | ||
| 2021-02-01 | Sale | PTC Therapeutics, Inc. PTCT | director | 506 0.0007% | $56.96 | $28,820 | -28.16% | |
| 2020-06-11 | Sale | PTC Therapeutics, Inc. PTCT | director | 364 0.0006% | $48.36 | $17,603 | +7.89% | |
| 2017-08-14 | Xenon Pharmaceuticals Inc. XENE | director | 100,000 0.6257% | $2.82 | $281,540 | +44.5% | ||
| 2017-05-23 | PTC Therapeutics, Inc. PTCT | director | 25,000 0.063% | $13.49 | $337,230 | +46.15% |